Skip to main content

MeVis Medical Solutions Value Stock - Dividend - Research Selection

MeVis Medical Solutions AG

ISIN: DE000A0LBFE4, WKN: A0LBFE

Market price date: 21.09.2020
Market price: 34,40 EUR




MeVis Medical Solutions AG Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 24-03-2020
Cash flow
Net operating cash flow 6.544.730
Capital Expenditures -202.922
Free cash flow 6.341.808
Balance sheet
Total Equity 17.826.000
Liabilities & Shareholders equity 23.919.800
Income statement
Net income 8.070.940
Eps (diluted) 4,435
Diluted shares outstanding 1.819.830
Net sales/revenue 18.073.400

Fundamental ratios calculated on: 21-09-2020

Ratios
Key figures 21-09-2020
Cash flow
P/C 9,57
   
P/FC 9,87
Balance sheet
ROI33,74
ROE74,52
Income statement
P/E7,76
Div. Yield2,76%
P/B3,51
P/S3,46


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolM3V.XETRA
Market Capitalization71.529.920,00 USD
CountryGermany
IndicesCDAX
SectorsHealth service
Raw Data SourceIFRS in Millionen EUR
Stock Split
Internetwww.mevis.de


Description of the company

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices and providers of medical IT platforms in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, prostate, and colon cancers, as well as neurological disorders. It operates in two segments, Digital Mammography and Other Diagnostics. The Digital Mammography segment develops and markets software products, which support breast diagnostic imaging and intervention. This segment also offers software applications for digital mammography, such as ultrasound, magnetic resonance imaging, and tomosynthesis. The Other Diagnostics segment provides digital radiology products, including magnetic resonance imaging and computer tomography for diseases, such as lung, prostate, and intestinal disorders, as well as general image-based analysis and diagnostics of radiology images. Its services are also used for lung diagnostics and general analysis of MR-image data; and technical visualization, which are used in training, for publication, presentations, and research purposes. This segment also provides interactive online training to enhance the diagnostic capabilities of clinical end customers. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG operates as a subsidiary of Varex Imaging Deutschland AG.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.mevis.de